Listen to our latest podcast, recorded live from the PharMerica booth at last week's AHCA/NCAL convention! Featuring AHCA/NCAL President Clif Porter and PharMerica President Scott Greenwell, and moderated by McKnight's John O'Connor, this conversation centers around the current triumphs and challenges in long-term care, as well as insights to help navigate the road ahead.
Medicare Part D: Guides for Communities & Residents
The Medicare Annual Enrollment Period is here and runs through December 7. This period gives individuals the chance to review their coverage and choose the plan that best fits their health and medication needs; however, it can be challenging to navigate. Our new guides break down important information about open enrollment and outline key Medicare changes taking effect on January 1, 2026.
This month is a great time to focus on practical strategies for managing Overactive Bladder (OAB) in older adults. Gemtesa® (vibegron) is a once-daily option that can help reduce urgency, frequency, and urge incontinence, with fewer drug interactions and no blood pressure warnings. Our OAB Treatment Algorithm provides a clear, step-by-step guide for assessing and managing OAB in long-term care settings.
When medications are crushed or altered without proper consideration, the results can include reduced effectiveness, unexpected side effects, or even safety risks. Our updated guide outlines which oral medications shouldn’t be crushed or split and why, so care teams have the clarity they need to help residents stay safe and well.
New White Paper: Medication Management in Senior Living
Medication management in senior living communities is evolving fast. Our new white paper explores how pharmacy services are stepping into a larger role, using technology, data, and insights to improve care outcomes, streamline operations, and support continuous quality improvement. Learn about current trends in senior living, the challenges communities face nationwide, and how the senior-care pharmacist is becoming a key partner in driving meaningful change.
This new Compliance Cue on MDS 3.0 Section N0415: High-Risk Drug Classes reviews which drug classes are flagged as high-risk, how to code them correctly, and how to make sure each medication has a clearly documented indication. Stay ahead of the changes and ensure your documentation is compliant.
LTC Survey Process: Approaches for Operational and Clinical Leadership to Reduce Risk and Improve Compliance
Tuesday, November 18
1:00 PM ET
The 2025 updates to Appendix PP of the LTC Survey Process require teams to strengthen care quality and documentation to meet new regulatory standards. This interactive webinar will review key issues, including oversight audits, compliance reviews, and Quality Measures changes effective January 1, 2026.
